Table 1. ALCAM and clinical parameters.

Variable, No. (%)	Σ	ALCAM Positive*	ALCAM Negative†	P-value
Superficial area of the tumor
FIGO	116	82 (70.7)	34 (29.3)	0.208
IA	56	42 (75.0)	14 (25.0)
IB	41	28 (68.3)	13 (31.7)
II	15	11 (73.3)	4 (26.7)
III	4	1 (25.0)	3 (75.0)
Grade	116	82 (70.7)	34 (29.3)	0.131
Grade I	79	60 (75.9)	19 (24.1)
Grade II	24	13 (54.2)	11 (45.8)
Grade III	13	9 (69.2)	4 (30.8)
Myometrial infiltration	116	82 (70.7)	34 (29.3)	0.541
< 50%	58	43 (74.1)	15 (25.9)
≥ 50%	58	39 (67.2)	19 (32.8)
Invasive front of the tumor
FIGO	106	71 (67.0)	35 (33.0)	0.004**
IA	53	42 (79.2)	11 (20.8)
IB	36	21 (58.3)	15 (41.7)
II	13	8 (61.5)	5 (38.5)
III	4	0 (0.0)	4 (100.0)
Grade	106	71 (67.0)	35 (33.0)	0.213
Grade I	72	52 (72.2)	20 (27.8)
Grade II	22	13 (59.1)	9 (40.9)
Grade III	12	6 (50.0)	6 (50.0)
Myometrial infiltration	106	71 (67.0)	35 (33.0)	0.014*
< 50%	55	43 (78.2)	12 (21.8)
≥ 50%	51	28 (54.9)	23 (45.1)

^*Positive ≥ 65 ^†Negative < 65.